Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Abstract:||The present invention relates to new taxoid-based compositions consisting of solutions of these derivatives in a surface-active agent. These solutions are used for preparing perfusion solutions.|
|Inventor(s):||Bobee; Jean-Marc (Verrieres-le-Buisson, FR), de Lanty; Patrick (Paris, FR), Guerin; Gilles (Eaubonne, FR), Veillard; Michel (Sceaux, FR)|
|Assignee:||Rhone-Poulenc Rorer S.A. (Antony Cedex, FR)|
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Compound;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|France||92 14501||Dec 02, 1992|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||190838||<disabled in preview>|
|Australia||5566994||<disabled in preview>|
|Australia||691476||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.